Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Clinical trial NCT03892434 · UNKNOWN

Trial details

NCT number: NCT03892434
Sponsor: Yeungnam University College of Medicine
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Branch Retinal Vein Occlusion With Macular Edema

Start date: 2019-03-18
Primary completion: 2019-12-18
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.